NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc

BACKGROUND: Cisplatin-based chemotherapy with concurrent radiotherapy is a standard treatment for advanced esophageal squamous cell carcinoma (ESCC). NS1-binding protein (NS1-BP), a member of the BTB-kelch protein family, has been shown to inhibit the proliferation of Hela cells by suppressing c-Myc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Commun (Lond)
Главные авторы: Wang, Yuwen, Cheng, Jingjing, Xie, Dan, Ding, Xiaofeng, Hou, Hailing, Chen, Xi, Er, Puchun, Zhang, Furong, Zhao, Lujun, Yuan, Zhiyong, Pang, Qingsong, Wang, Ping, Qian, Dong
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5993120/
https://ncbi.nlm.nih.gov/pubmed/29871674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-018-0307-y
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы